Massachusetts Biotechnology Consortium President and CEO Robert Coughlin visited. Joined by Executive VP Sara MacDonald and State Government Relations/Federal and State Policy Consultant John Heffernan, the group enjoyed discussing the new relationship between both organizations as well as a tour of the facility.
Impact of FirstDatabank’s decision to no longer list compounding kits, resulting in new barriers in patient access to needed therapies, highlighted in Boston Globe article. Click here to read the full article.
State Rep Jeffrey Sánchez, Chairman of the Joint Committee on Health Care Financing visited, joined by Sarah Sabshon, Chief of Staff, and Timothy O’Neill, Research Director for the Committee. During their visit, they met with our Executive team and took a group tour of the facility.
Neal Muni, MD, MSPH is promoted to Chief Executive Officer.
Wilmington, MA (May 19, 2015) – CutisPharma, a specialty pharmaceutical company that develops and distributes bulk drugs in kits used by pharmacists to create compounded medications, today named President Neal Muni, MD, MSPH to the role of Chief Executive Officer.
Neal Muni replaces Indu Muni, Ph.D., who […]
Former Patriot and football legend Steve Nelson stopped by to wish Company founders Dr. Indu and Gita Muni a happy farewell. Indu and Gita founded CutisPharma back in 2000 and moved on to new adventures in May of 2015. While their departure was bittersweet they left behind a wonderful foundation which employees continue to build […]
CutisPharma, a specialty pharmaceutical company focusing on the development and commercialization of value-added kits for the compounding pharmacy market, announced today that it has closed an equity financing with Ampersand Capital Partners.
WILMINGTON, MA – January 6, 2015 – As a part of the transaction, Silicon Valley Bank has provided a senior credit facility to further […]
CutisPharma announced today that it has appointed Neal Muni, MD, MSPH as President and member of the Board of Directors. Dr. Muni will assume responsibility for overseeing the company’s commercial operations and guiding development strategy for it’s product portfolio.
WILMINGTON, MA – July 15, 2014 – “We are pleased that Neal has joined our team to […]
Use of FIRST® Kits facilitates compliance with USP Chapter
Woburn, Mass., December 19, 2012 – CutisPharma, Inc. today announced that the United States Patent and Trademark Office has issued a patent (US 8,276,757 B2) regarding a method for the preparation, storage and dispensing of compounded suppositories. The FIRST® container (suppository mold) and the method […]
CutisPharma, Inc. announced the presentation of homogeneity and stability studies for compounded formulations of several “Magic Mouthwash” suspensions using FIRST® Unit- of- Use Prescription Compounding Kits.
Woburn, Mass., May 15th 2012 – CutisPharma, Inc. announced the presentation of homogeneity and stability studies for compounded formulations of several “Magic Mouthwash” suspensions using FIRST® – Unit- of- […]
FIRST® – Omeprazole and FIRST® – Lansoprazole Unit-of-Use compounding kits make pharmacy compounding easier
Woburn, Mass., January 19, 2012 – CutisPharma, Inc. announced the introduction of FIRST® – Omeprazole and FIRST® – Lansoprazole Unit-of-Use oral suspension compounding kits. These new kits will help pharmacists dispense these compounded prescriptions containing widely used proton pump inhibitors (PPIs). Traditionally, […]
FIRST® – Mouthwash BLM 4oz and FIRST® – Mouthwash BLM 6oz Unit-of-Use compounding kit provides prescription flexibility
Woburn, Mass., December 21, 2011 – CutisPharma, Inc. announced the introduction of FIRST® – Mouthwash BLM 4oz and FIRST® – Mouthwash BLM 6oz compounding kits. These products expand the FIRST® Magic Mouthwash line for CutisPharma. The product line already […]
FIRST® – Duke’s Mouthwash and FIRST® – Mary’s Mouthwash Unit-of-Use compounding kit makes pharmacy compounding easier
Woburn, Mass., January 5, 2011 – CutisPharma, Inc. announced the introduction of FIRST® – Duke’s Mouthwash and FIRST® – Mary’s Mouthwash compounding kits. These products complete the FIRST® Magic Mouthwash line for CutisPharma. The product line already includes FIRST® – […]
US patent for the method of preparation, storage, and dispensing of compounded suppositories
Woburn, Mass., October 27, 2010 – CutisPharma, Inc. today announced that it has received approval from the United States Patent and Trademark Office for its patent (US 7,815,929) regarding a method for the preparation, storage and dispensing of compounded suppositories.
“By its very […]
FIRST® – BXN Mouthwash Unit-of-Use compounding kit makes pharmacy compounding easier
Woburn, Mass., September 22, 2009 – CutisPharma, Inc. announced the introduction of FIRST® – BXN Mouthwash. It is the second in the FIRST® Mouthwash Compounding Kit product line, which already includes FIRST® – Mouthwash BLM. The active ingredients in FIRST® – BXN Mouthwash are […]
Accreditation is designed to preserve the safety and integrity of the pharmaceutical supply chain
Woburn, Mass., June 23, 2009 – CutisPharma, Inc. announced today that it has received Verified Accredited Wholesale Distributors (VAWD) accreditation from the National Association of Boards of Pharmacy (NABP) for its Woburn, Massachusetts facility. In March 2007 the company received accreditation for […]
Recent Comments